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The phenomenon of programmed cell death (PCD), in 
which cells initiate their own demise, is not restricted 
to multicellular organisms. Unicellular organisms, both 
eukaryotes and prokaryotes, also possess pathways 
that mediate PCD. We recently identified a PCD mech-
anism in Escherichia coli that is triggered by a mutant 
isoform of the essential GTPase ObgE (Obg of E. coli). 
Importantly, the PCD pathway mediated by mutant 
Obg (Obg*) differs fundamentally from other previous-
ly described bacterial PCD pathways and thus consti-
tutes a new mode of PCD. ObgE was previously pro-
posed to act as a cell cycle checkpoint protein able to 
halt cell division. The implication of ObgE in the regula-
tion of PCD further increases the similarity between 
this protein and eukaryotic cell cycle regulators that 
are capable of doing both. Moreover, since Obg is con-
served in eukaryotes, the elucidation of this cell death 
mechanism might contribute to the understanding of 
PCD in higher organisms. Additionally, if Obg*-
mediated PCD is conserved among different bacterial 
species, it will be a prime target for the development 
of innovative antibacterials that artificially induce this 
pathway. 
 
Although the discovery of programmed cell death (PCD) in 
unicellular organisms like bacteria was initially met with 
criticism and disbelief, the importance of bacterial PCD is 
increasingly being recognized by the scientific community. 
Many reports have demonstrated the existence of 
genetically encoded cell death pathways in bacteria and 
several different PCD mechanisms have been described. 
The physiological benefit of maintaining these cell death 
mechanisms in unicellular organism however, is still a point 
of speculation and ongoing debate. Many researchers 
believe that bacteria undergo PCD for the benefit of their 
kin and preservation of the bacterial population as a 
whole. Scientific evidence supporting this hypothesis 
remains limited and further research is necessary. 
Serendipitous discovery of a mutant isoform of the 
essential GTPase ObgE led to the identification of a new 
bacterial PCD pathway. The gene encoding this mutant 
isoform carries a single point mutation, leading to the 
formation of ObgEK268I, further denoted as ObgE*. 
Interestingly – while ObgE is essential for viability – 
expression of ObgE* leads to a rapid and large decrease in 
viability. This loss of viability appears to occur through a 
highly coordinated process ultimately leading to cell death. 
During this process, an array of different PCD markers can 
be detected, thus classifying ObgE*-mediated cell death as 
a PCD mechanism. At the level of the DNA, we observed 
chromosome condensation and DNA fragmentation. 
Changes at the membrane include membrane 
depolarization, exposure of phosphatidylserine on the cell 
surface and the extensive formation of membrane blebs 
(shown in Figure 1). 
There is a remarkable resemblance between the 
physiological changes that occur during ObgE*-mediated 
PCD and eukaryotic apoptosis. All the PCD markers 
observed during the former are typical markers of 
apoptosis as well. Importantly, Obg is a strongly conserved 
protein that is also present in higher eukaryotes. 
Moreover, the human Obg homologue that is most similar 
to ObgE, ObgH1, localizes to mitochondria, the key 
organelles of the intrinsic pathway of apoptosis. It is 
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therefore possible that an evolutionary link between 
ObgE*-mediated PCD and apoptosis exists and that our 
results will contribute towards a better understanding of 
the mechanism and evolution of PCD in eukaryotes.  
The cell death mechanism triggered by ObgE* is unlike 
any bacterial PCD mechanism reported to date. Although it 
displays many physiological similarities with so called 
‘apoptosis-like death’, the key regulator of the latter 
process, RecA, does not affect ObgE*-mediated PCD. 
Likewise, holin-like proteins that might facilitate autolysis 
are not involved in ObgE*-mediated cell death and neither 
is the toxin-antitoxin module mazEF. So far, the pathway 
that causes this new form of PCD remains unknown. 
Another unanswered research question concerns the 
activation of this newly discovered mechanism. In our 
experimental set-up we induce PCD by expression of the 
mutant protein ObgE*. We believe however, that this 
mechanism can also be triggered by wild-type ObgE under 
natural conditions. Possibly a post-translational 
modification or protein-protein interaction involving ObgE 
triggers cell death. Further research on ObgE*-mediated 
PCD is therefore also likely to contribute to our 
understanding of the functions of the wild-type ObgE 
protein. 
ObgE was previously suggested to act as a cell cycle 
checkpoint protein. This essential GTPase is involved in 
ribosome assembly, the stringent response, DNA 
replication and chromosome segregation. It is believed 
that ObgE functions to link these processes and coordinate 
them with cell division. Since overexpression and depletion 
of ObgE can halt cell division, and since ObgE might also 
induce PCD under certain physiological conditions, it 
appears as though this protein acts much like eukaryotic 
cell cycle regulators do. These regulators are indeed also 
capable of inhibiting cell division or inducing PCD when the 
cell cycle does not proceed normally. One of the functions 
of these eukaryotic proteins is thus to eliminate rogue cells 
that could bring harm to the organism if left unchecked. 
What the physiological relevance and evolutionary 
advantage of elimination of bacterial cells with aberrant 
cell cycles might be, remains to be determined.   
The discovery of bacterial PCD has opened up the 
possibility of developing a new class of antibacterials 
targeted at the artificial activation of PCD in bacteria. In 
light of the looming antibiotic crisis, such novel ways to 
combat bacterial infections are desperately needed. Since 
Obg is conserved among bacteria, the PCD mechanism 
triggered by ObgE* might be a prime target for the 
development of such novel therapeutics. 
In summary, we have identified a mutant isoform of 
ObgE, called ObgE*, that triggers programmed cell death in 
E. coli. This PCD mechanism is distinct from other 
previously described bacterial PCD pathways because key 
regulators of these pathways were shown not to be 
involved in ObgE*-mediated cell death. We have therefore 
discovered a new mode of PCD in E. coli. Further 
investigation of this mechanism holds promise in the 
further understanding of the functions of wild-type ObgE, 
the evolution of eukaryotic PCD pathways and the 
development of a novel class of innovative antibacterials 
that exploit bacterial PCD mechanisms to combat bacterial 
infections.  
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FIGURE 1: SEM image of E. coli undergoing ObgE*-mediated PCD. 
Expression of ObgE* causes the extensive formation of membrane 
blebs. 
